‹ All stocks
Apollomics
APLMW · NASDAQ · Healthcare
$0.01
▼ $0.01 (-16.03%)
Day range
$0.01 – $0.01
Year range
$0.01 – $0.23
Open
$0.01
Previous close
—
Market cap
$162.58M
Volume (24h)
$100
Volume (52w)
$1
Performance
7D
▼ -5.17%
1M
▼ -20.29%
3M
▼ -42.11%
6M
▼ -29.49%
1Y
▼ -57.69%
YTD
▼ -16.67%
3Y
▼ -72.50%
5Y
▼ -90.85%
All-time
▼ -90.85%
Key statistics
P/E ratio
0.00
EPS (TTM)
$-307.28
Dividend yield
—
Dividend (TTM)
—
Payout ratio
—
Shares outstanding
14.8B
About Apollomics
Apollomics, Inc. functions as a clinical-phase biotechnology enterprise, concentrating its efforts on discovering and advancing novel cancer treatments to meet crucial, underserved patient requirements. The company was co-founded by Liang Yu Guo and Sanjeev Redkar in 2015, with its main operations based in Foster City, California.
Visit websiteCountry: United States of America
More in Healthcare
LLY Eli Lilly and Company |
$1149.85 | -0.62% |
JNJ Johnson & Johnson |
$258.66 | -2.30% |
ABBV AbbVie |
$260.03 | -0.60% |
MRK Merck & Co. |
$143.81 | -1.03% |
UNH UnitedHealth Group Incorp… |
$365.20 | -0.51% |